Publications

Find at Harvard

October 2020 (Revised April 2022)
Case

When Institutions Fail: HIV/AIDS in the 1980s

By: Tom Nicholas and Christian Godwin

During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting... View Details

Article

The Unprecedented Stock Market Reaction to COVID-19

By: Scott Baker, Nicholas Bloom, Steven J. Davis, Kyle Kost, Marco Sammon and Tasaneeya Viratyosin

No previous infectious disease outbreak, including the Spanish Flu, has impacted the stock market as forcefully as the COVID-19 pandemic. In fact, previous pandemics left only mild traces on the U.S. stock market. We use text-based methods to develop these points with... View Details

Keywords: COVID-19; Stock Market; Health Pandemics; Governance; Policy; Financial Markets

Find at Harvard

29 May 2020
Op-Ed

How Leaders Are Fighting Food Insecurity on Three Continents

COVID-19 is creating unprecedented strains on food security worldwide. The United Nations' World Food Programme warns that the pandemic could almost double the number of people facing food crises in low- and middle-income populations to 265 million by the end of 2020.... View Details

Keywords: by Howard Stevenson and Shirley Spence; Agriculture & Agribusiness

23 Jun 2023
HBS Case

This Company Lets Employees Take Charge—Even with Life and Death Decisions

care teams after experiencing firsthand as a nurse, and then a decade as a senior leader of two large health care organizations, how the health care system managed quality and productivity in ways that... View Details

Keywords: by Annelena Lobb; Health

Article

Ushering in Safe, Effective, Secure, and Ethical Medicine in the Digital Era

By: William J. Gordon, Andrea Coravos and Ariel Dora Stern

From clinical trials to care delivery, advanced, digitally enabled technologies and analytics offer new approaches to how we think about medicine, health, and biology. The COVID-19 pandemic has accelerated this conversation, and forced a roadmap, once measured in years... View Details

Keywords: Digital Medicine; Health Care and Treatment; Technological Innovation; Safety; Ethics

Winter 2022
Article

Vaccines and the COVID-19 Pandemic: Lessons from Failure and Success

By: Scott Duke Kominers and Alex Tabarrok

The losses from the global COVID-19 pandemic have been staggering—trillions in economic costs, on top of significant losses of life, health, and well-being. The world made significant and successful investments in vaccines to mitigate the pandemic, yet there were... View Details

Keywords: COVID-19; Vaccination; Market Design; Health Pandemics; Loss; Outcome or Result; Opportunities; Crisis Management

2021
Case

Leading Through Challenging Times: Atlanta Mayor Keisha Lance Bottoms

By: Michael Norris, Rawi Abdelal and Kimberlyn Leary

Keisha Lance Bottoms took office as Mayor of Atlanta in 2018 with a progressive agenda and hopes to “keep Atlanta moving forward, leaving no one behind.” She was an Atlanta native, had previously served as a local judge and city councilor, and came into office with... View Details

Keywords: Leadership; City; Problems and Challenges; Health Pandemics; Social Issues; Economy; Atlanta; United States

March 27, 2020
Other Article

Lessons from Italy's Response to Coronavirus

By: Gary P. Pisano, Raffaella Sadun and Michele Zanini

Policymakers in many parts of Europe and the United States are struggling to bring the rapidly spreading Covid-19 pandemic under control. In doing so, they are repeating many of the mistakes made in Italy, where the pandemic turned into a disaster. A major contributing... View Details

Keywords: COVID-19; Health Pandemics; Crisis Management; Government and Politics; Decision Making; Italy

25 Jul 2023
Research & Ideas

Could a Business Model Help Big Pharma Save Lives and Profit?

more critical than ever for Big Pharma to adopt it more broadly. He says the pandemic elevated urgency by: Exposing new risks and opportunities with Big Pharma’s current models. Driving global use of video-conferencing technology, which... View Details

Keywords: by Esther Schrader; Health; Health

21 May 2020
Research & Ideas

Fighting the COVID Blues: Advice from Business Research

More Business-Related Pandemic Coverage from Around Harvard and Beyond COVID-19 Business Impact Center (Harvard Business School) Your CEO Succession Plan Can’t Wait (Harvard Business Review) A Pandemic Won’t... View Details

Keywords: by Dina Gerdeman and Danielle Kost

April 2021 (Revised December 2023)
Case

The Mahindra Group: Leading with Purpose

By: Ranjay Gulati and Rachna Tahilyani

India headquartered Mahindra Group is a multibillion-dollar federation of companies operating across the globe. It is ahead of its time in articulating its purpose and mapping its values, something it had first done at inception and then refreshed yet again as ‘Rise’... View Details

Keywords: Mission and Purpose; Organizational Culture; Change Management; Communication Strategy; Family Ownership; Corporate Social Responsibility and Impact; Revenue; Auto Industry; Financial Services Industry; Manufacturing Industry; Technology Industry; Asia; India; Mumbai; South Korea; Italy; United States

23 Feb 2021
Research & Ideas

COVID-19 Shines New Light on Working Conditions in Supply Chains

more than 20 years, the devastation in meatpacking is just one example of how lax regulation can make a grave situation deadly. The lack of safety guidance from the US Occupational Health and Safety Administration (OSHA) nearly a year... View Details

Keywords: by Danielle Kost; Apparel & Accessories

2023
Article

Comparison of COVID-19 Hospitalization Costs across Care Pathways: A Patient-level Time-driven Activity-based Costing Analysis in a Brazilian Hospital

By: Ricardo Bertoglio Cardoso, Miriam Allein Zago Marcolino, Milena Soriano Marcolino, Camila Felix Fortis, Leila Beltrami Moreira, Ana Paula Coutinho, Nadine Oliveira Clausell, Junaid Nabi, Robert S. Kaplan, Ana Paula Beck da Silva Etges and Carisi Anne Polanczyk

The COVID-19 pandemic raised awareness of the need to better understand where and how patient-level costs are incurred in health care organizations. This study used time-driven activity-based costing to estimate COVID-19 patient-level hospital costs in a Brazilian... View Details

Keywords: Health Care and Treatment; Cost; Health Industry; Brazil

July 2020
Case

Michael Solomonov: Jerusalem in a Bowl

By: Boris Groysberg, Evan M.S. Hecht and Katherine Connolly Baden

Before the COVID-19 pandemic hit, Michael Solomonov and Steven Cook had begun to wonder whether it might be time to rethink their opportunistic approach to the expansion of their small restaurant empire in Philadelphia, CooknSolo. The pandemic, however, caused an... View Details

Keywords: Restaurant Industry; Entrepreneur; COVID-19; Crisis; Crisis Response Plans; Entrepreneurship; Food; Health Pandemics; Crisis Management; Innovation and Invention; Leadership; Creativity; Strategy; Ownership; Problems and Challenges; Risk and Uncertainty; Situation or Environment; Food and Beverage Industry; United States

August 2020
Case

Zoom Video Communications: Eric Yuan's Leadership During COVID-19

By: Scott Duke Kominers, Christopher Stanton, Andy Wu and George Gonzalez

In the first half of 2020, worldwide lockdowns caused by the COVID-19 pandemic brought explosive growth to the Zoom Video Communications platform, as people replaced in-person work and social events with videoconferencing. Months into the pandemic, CEO Eric Yuan... View Details

Keywords: Transformation; Communication Technology; Customer Value and Value Chain; Values and Beliefs; Technological Innovation; Leadership; Crisis Management; Organizational Culture; Working Conditions; Strategy; Information Technology; Applications and Software; Technology Adoption; Health Pandemics; Technology Industry; United States; California

November 2020
Case

Valuing Celgene's CVR

By: Benjamin C. Esty and Daniel Fisher

When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details

Keywords: Mergers and Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Biotechnology Industry; United States

November 3, 2020
Article

Gender Differences in COVID-19 Attitudes and Behavior: Panel Evidence from Eight Countries

By: Vincenzo Galasso, Vincent Pons, Paola Profeta, Michael Becher, Sylvain Brouard and Martial Foucault

Using original data from two waves of a survey conducted in March and April 2020 in eight OECD countries (N = 21,649), we show that women are more likely to see COVID-19 as a very serious health problem, to agree with restraining public policy measures adopted in... View Details

Keywords: COVID-19; Health Pandemics; Attitudes; Behavior; Gender; Policy; Governance Compliance

Find at Harvard